The “best” peptide depends entirely on what you’re trying to achieve. Peptides are short chains of amino acids that signal specific processes in your body, and different ones target different goals: injury recovery, muscle growth, fat loss, skin quality, cognitive performance, and more. Most are administered by injection because oral forms lose nearly all their potency during digestion, with bioavailability dropping to roughly 1% compared to a subcutaneous dose. Here’s a breakdown of the most widely used peptides by category and what the evidence actually shows.
Injury Recovery: BPC-157 and TB-500
These two peptides are the go-to options for tendon, ligament, and muscle injuries, and they’re often stacked together. BPC-157 is a synthetic version of a protective protein found in stomach acid. In animal studies, it promotes new blood vessel growth, increases nitric oxide production, and stimulates collagen formation, all of which are critical for rebuilding damaged tissue. TB-500, a fragment of a naturally occurring protein called Thymosin Beta-4, works by regulating actin, a protein essential for cell movement and repair. It encourages cells to migrate toward injury sites and helps form new blood vessels.
Together, they appear to improve circulation, reduce inflammation, and speed up the cellular responses that allow injured tissue to rebuild. The combination is sometimes called the “Wolverine stack” in peptide communities. The caveat: most of the evidence comes from animal models, not human clinical trials. The FDA has flagged BPC-157 specifically, noting that it lacks sufficient safety data for human use and that compounded versions may carry risks related to impurities and immune reactions. It is not FDA-approved for any human condition, and compounding pharmacies that previously offered it have faced increasing regulatory scrutiny.
Muscle Growth and Recovery: CJC-1295 and Ipamorelin
This combination is the most popular growth hormone secretagogue stack, meaning it stimulates your pituitary gland to release more of its own growth hormone rather than introducing synthetic growth hormone directly. CJC-1295 extends the duration of growth hormone release, while Ipamorelin triggers a sharper pulse. Together, they produce a stronger and longer-lasting growth hormone spike than either one alone, which supports muscle repair, collagen synthesis, fat metabolism, and deeper sleep.
Typical protocols start at 0.6 mg daily during the first week, gradually increasing to 2.0 mg daily by the end of the second month, then holding steady at that maintenance dose. Most cycles run one to three months on, followed by two to three months off, with a common weekly schedule of five days on and two days off. Results tend to be subtle compared to direct growth hormone injections. You’re more likely to notice improved sleep quality and faster recovery from workouts before you see visible changes in body composition.
Because these peptides elevate growth hormone levels, they carry some of the same risks associated with excess growth hormone: joint and muscle pain, swelling in the hands and feet, elevated blood sugar, and in some cases a higher risk of insulin resistance over time. Carpal tunnel symptoms and breast tissue enlargement in men have also been reported with sustained growth hormone elevation.
Weight Loss: Semaglutide and Tirzepatide
These are the peptide-based medications behind the brand names you’ve likely heard of. Semaglutide activates GLP-1 receptors, which reduce appetite, slow stomach emptying, and improve blood sugar control. Tirzepatide activates both GLP-1 and GIP receptors, giving it a dual mechanism. In a systematic review of phase 3 trials, tirzepatide at its mid and high doses produced roughly 4% to 5.4% more total body weight loss than semaglutide at its standard 2.4 mg dose, along with greater reductions in blood sugar markers and fewer gastrointestinal side effects.
Both require a prescription and are FDA-approved for specific indications. They’re injected once weekly, and nausea is the most common side effect, particularly during dose escalation. These are the most rigorously studied peptides on this list, with large-scale human trials supporting their use.
Skin and Anti-Aging: GHK-Cu
GHK-Cu is a copper-binding peptide that your body produces naturally, though levels decline with age. It stimulates collagen production and increases glycosaminoglycans, the molecules that help skin retain moisture and structure. It also improves wound healing in both lab and clinical settings. What makes it unusual among peptides is that it influences genes involved in tissue regeneration and inflammation, behaving in some ways like a growth factor.
GHK-Cu is available in both injectable and topical forms. Topical versions are the most accessible, found in serums and creams, though penetration through the skin barrier limits how much reaches deeper tissue. For skin texture, fine lines, and overall tone, topical copper peptide products are one of the more evidence-supported options in the anti-aging peptide space.
Cognitive Performance: Semax
Semax is a synthetic peptide originally developed in Russia for neurological conditions. It increases levels of brain-derived neurotrophic factor (BDNF), a protein that supports neuron survival, growth, and the formation of new neural connections. Higher BDNF levels are closely tied to better learning and memory. Semax also enhances the activity of dopamine and serotonin, which can improve mood and reduce anxiety, and it has antioxidant properties that protect neurons from oxidative damage.
On top of that, Semax reduces the production of inflammatory molecules in the brain, offering a layer of neuroprotective benefit. It’s typically administered as a nasal spray, which gives it an advantage over injectable peptides in terms of convenience. Selank, a related peptide, is often mentioned alongside it for its anti-anxiety effects, though Semax has more data supporting cognitive enhancement specifically. Neither is FDA-approved in the United States.
Sexual Health: Bremelanotide (PT-141)
Bremelanotide is one of the few peptides on this list with full FDA approval. It’s prescribed for hypoactive sexual desire disorder in premenopausal women and works through a completely different pathway than medications like sildenafil. Rather than increasing blood flow, it activates receptors in the brain that influence sexual arousal and desire. The standard dose is 1.75 mg injected subcutaneously at least 45 minutes before sexual activity, with a maximum of one dose per 24 hours and no more than eight doses per month. Nausea and flushing are the most common side effects.
Longevity: Epitalon
Epitalon is a four-amino-acid peptide that activates telomerase, the enzyme responsible for maintaining telomere length. Telomeres are the protective caps on the ends of chromosomes that shorten each time a cell divides, and their erosion is one of the hallmarks of biological aging. Lab research has shown that Epitalon treatment significantly improves telomerase activity, and a recent study published in Life Sciences demonstrated that it enhanced cell quality and health markers in treated samples compared to controls. The interest in Epitalon is centered on whether maintaining telomere length could slow aspects of cellular aging, but human clinical data remains thin. Most of the existing research comes from cell and animal studies.
Practical Considerations for All Peptides
The biggest practical barrier with peptides is bioavailability. Oral peptide formulations lose the vast majority of their active compound during digestion. For semaglutide, switching from injection to oral requires roughly a 100-fold increase in dose to achieve the same effect: 1 mg injected versus 98 mg taken orally. For most other peptides, oral bioavailability hovers around 1% with current formulations, which is why subcutaneous injection remains the standard route. Some newer delivery systems have achieved bioavailability above 60% in early trials, but these are not widely available yet.
Injection site reactions, including redness, swelling, and mild pain, are common across nearly all injectable peptides. Growth hormone-related peptides carry additional risks with prolonged use: water retention, joint pain, elevated blood sugar, and potentially increased cancer risk with sustained growth hormone elevation. The Mayo Clinic lists carpal tunnel syndrome, type 2 diabetes, edema, and gynecomastia among the known side effects of elevated growth hormone in otherwise healthy adults.
Regulatory status varies widely. Semaglutide, tirzepatide, and bremelanotide are FDA-approved with clear prescribing guidelines. BPC-157, TB-500, Semax, and Epitalon occupy a gray area: available through compounding pharmacies, research chemical suppliers, or international sources, but without FDA approval for human use. The FDA has specifically noted that compounded BPC-157 products may present safety risks due to impurity concerns and a lack of human safety data. If you’re considering any peptide outside the FDA-approved options, sourcing from a reputable compounding pharmacy with third-party testing is the minimum standard for reducing contamination risk.